Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Shiftwave has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Nervous System Regulation Devices Company Of The Year- 2025,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Dr. Mike North, CEO, CTO and Co-founder, Dr. Jeff Rouse. .
This groundbreaking work soon led to a Department of Defense (DOD) project, where they developed smart prosthetics for veterans. These prosthetics restored mobility and gathered insights into the wearer’s stress levels and emotional state—data that proved highly valuable.![]()
Jeff and I have traveled to Ukraine multiple times and have been actively engaged in efforts to make a meaningful impact since the onset of the war
This breakthrough has positioned Shiftwave at the forefront of active neuroregulation, a rapidly growing field dedicated to non-invasive ways of enhancing brain function and emotional resilience.What makes Shiftwave distinctive in the nervous system regulation technology market?
Shiftwave focuses on developing technology intended to support nervous system balance and physiological regulation through noninvasive therapeutic approaches. Its work in nervous system regulation devices centers on helping users manage neurological and physiological responses with technologies designed for consistent usability and therapeutic support. The company combines technology development with an emphasis on user experience, creating solutions that align with growing interest in wellness-oriented and neuroregulation-focused healthcare technologies.
How does Shiftwave support users through its nervous system regulation devices?
Ease of use and therapeutic accessibility play important roles in the company’s product philosophy. Shiftwave develops nervous system regulation devices designed to integrate into structured care or wellness routines while maintaining practical usability. Its technology aims to support users through guided neuroregulation experiences that emphasize comfort, consistency and measurable engagement. This focus helps create a more approachable experience for individuals and organizations adopting neurotechnology-based solutions.
Why is nervous system regulation becoming increasingly relevant?
Interest in neurological wellness and physiological regulation technologies continues to grow across healthcare and wellness environments. Shiftwave addresses this demand through nervous system regulation devices developed to support relaxation, balance and nervous system responsiveness. As awareness of neuroregulation technologies expands, the company’s focus on noninvasive therapeutic support positions it within a market increasingly interested in technology-enabled wellness and recovery approaches.
What role does innovation play in Shiftwave’s technology development?
Innovation at Shiftwave centers on refining how neuroregulation technologies are experienced and applied. The company continues improving its nervous system regulation devices with attention to usability, treatment consistency and user interaction. Its development efforts focus not only on technological performance but also on creating solutions that support practical adoption and long-term engagement. This balanced strategy helps the company remain aligned with evolving expectations surrounding neurotechnology and wellness-focused therapeutic tools.
How does Shiftwave create value for healthcare and wellness environments?
Organizations and users evaluating nervous system regulation devices often prioritize technologies that combine therapeutic support with usability and adaptability. Shiftwave addresses these priorities through systems designed to support individualized neuroregulation experiences while maintaining operational simplicity. Its emphasis on accessible technology and user-centered design contributes to broader applicability across environments focused on wellness support and physiological regulation.
Why is Shiftwave recognized among top nervous system regulation device companies?
Shiftwave has gained recognition by concentrating on technology-driven approaches to neuroregulation and physiological support. Its nervous system regulation devices reflect a commitment to noninvasive therapeutic innovation, usability and user engagement. By focusing on practical neurotechnology applications and consistent therapeutic experiences, the company continues to strengthen its relevance within the evolving nervous system regulation technology landscape.
Company
Shiftwave
Management
Dr. Mike North, CEO, CTO and Co-founder, Dr. Jeff Rouse.
Description
Shiftwave is a neurotechnology company integrating vibrokinetic therapy, biometrics, and AI to optimize mental health and human performance. Founded by scientists, it delivers passive nervous system regulation, reducing stress, enhancing focus, and accelerating recovery for individuals, athletes, corporations, and humanitarian efforts.
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
